Biodeal Pharmaceuticals
Biodeal Pharmaceuticals is an India-based, Noida-headquartered pharmaceutical manufacturer founded in 2005 that produces tablets, nasal sprays, and ointments, and is investing in a new USFDA-compliant facility to access regulated export markets.
- Company typePrivate
- Founded2005
- HeadquartersNoida, India
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biodeal Pharmaceuticals does
Biodeal Pharmaceuticals Ltd is a privately held pharmaceutical manufacturing company headquartered in Noida, India. Founded in 2005, the company produces finished dosage formulations including tablets, nasal sprays, and ointments. It operates with a workforce of 101-250 employees and is led by founder and owner Anurag Kumar. The entity is incorporated as an Indian private limited company with no public listing.
The company's near-term growth trajectory is anchored by a ₹110 crore (approximately $13.2 million USD) investment from Piramal Alternatives in April 2024, structured through convertible instruments. Proceeds are explicitly earmarked for infrastructure upgrades, technology investment, expanded manufacturing capacity, and the construction of a new USFDA-compliant facility — a move that signals intent to access regulated export markets, particularly the United States. No customer names, revenue figures, product pricing, distribution channels, or specific technology stack have been publicly disclosed in the available source material.
Given the absence of disclosed customer, pricing, or revenue data, the underlying business model can only be described at a high level: a contract/generic pharmaceutical manufacturer producing multi-format finished dosage forms from a single Indian site, with go-to-market channels (B2B institutional, distributor, government tender, export) not specified in the source. No software platform, digital product, app, API, or AI/ML capability is documented.
Biodeal Pharmaceuticals firmographics
Firmographics- Name
- Biodeal Pharmaceuticals
- Legal name
- Biodeal Pharmaceuticals Ltd
- Website
- https://biodealpharma.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Biodeal Pharmaceuticals is an India-based, Noida-headquartered pharmaceutical manufacturer founded in 2005 that produces tablets, nasal sprays, and ointments, and is investing in a new USFDA-compliant facility to access regulated export markets.
- Ownership category
- akta.pro rank
Biodeal Pharmaceuticals industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule API Commercial Manufacturing (HLAGAHAB)
- akta.pro secondary industry
- Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
Keywords
Where Biodeal Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Noida
- HQ country
- India
- HQ region
- Asia
Markets served
Biodeal Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Biodeal Pharmaceuticals product offering
Product offeringCore offering
Biodeal Pharmaceuticals is a private pharmaceutical manufacturer based in Noida, India that produces finished dosage forms including tablets, nasal sprays, and ointments. The company is investing in a new USFDA-compliant manufacturing facility to expand production capacity and pursue regulated market approvals.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Tablets
- Nasal Sprays
- Topical Ointments
Companies that use Biodeal Pharmaceuticals
Customer profileIdeal customer profiles1 record
Biodeal Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Biodeal Pharmaceuticals partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights4 records
Biodeal Pharmaceuticals competitors and assessment
Company assessmentBroad incumbents
- Zydus Lifesciences (Cadila Healthcare): Indian pharmaceutical manufacturer with extensive generics portfolio across oral solids, nasal, and topical formulations, plus multiple USFDA-inspected facilities. Directly comparable to Biodeal in dosage forms and regulatory pathway ambitions.
- Sun Pharmaceutical Industries: India's largest specialty generics company with broad oral solid, injectable, and topical (including ointments) manufacturing capabilities. Directly comparable therapeutic-area formats and USFDA-regulated supply chain footprint, though at enterprise scale.
- Cipla: One of India's largest generic pharmaceutical manufacturers with extensive nasal spray, inhalation, and oral solid dosage form portfolios. Directly comparable to Biodeal in therapeutic formats (notably nasal sprays) and in targeting regulated export markets, though at vastly larger scale.
- Glenmark Pharmaceuticals: Indian-headquartered pharma company with generics and specialty dermatology/topicals pipeline. Comparable to Biodeal in operating from India with exposure to both domestic generics and USFDA-licensed manufacturing.
- Lupin: Indian pharmaceutical manufacturer with strong generics and specialty pipeline, multiple USFDA-approved plants, and dosage form coverage including tablets and semi-solids. Comparable to Biodeal as an Indian-headquartered generic manufacturer targeting regulated markets.
- Aurobindo Pharma: Large Indian generic manufacturer with significant US ANDA exposure, oral solids, and injectables manufacturing. Comparable to Biodeal in generics manufacturing model and USFDA-licensed facility strategy, though at substantially greater scale and product breadth.
- Dr. Reddy's Laboratories: Indian-headquartered integrated pharmaceutical manufacturer with global generics presence including nasal sprays and topical products. Comparable to Biodeal across multiple dosage forms and in pursuing regulated-market expansion.
- Torrent Pharmaceuticals: Mid-to-large Indian pharmaceutical company with generics focus, including tablets, injectables, and topical formulations, plus a growing international footprint. Comparable to Biodeal as a domestically-anchored Indian generics manufacturer scaling into regulated markets.
Direct peers
- Unichem Laboratories: Mid-sized Indian pharmaceutical manufacturer specializing in generic tablets, injectables, and topical formulations with USFDA-approved plants. Closest comparable to Biodeal in scale, dosage-form mix (oral solids + topicals/ointments), and positioning as a mid-tier Indian generics manufacturer pursuing US exports.
- Morepen Laboratories: Indian pharmaceutical manufacturer with focus on generics, APIs, and OTC dosage forms including tablets and nasal preparations. Comparable to Biodeal in mid-tier scale, dosage form coverage, and Indian-headquartered generics manufacturing profile.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Biodeal Pharmaceuticals social profiles
Digital presenceBiodeal Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biodeal Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles1 record
Biodeal Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biodeal Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biodeal Pharmaceuticals
What does Biodeal Pharmaceuticals do?
Biodeal Pharmaceuticals is a private pharmaceutical manufacturer based in Noida, India that produces finished dosage forms including tablets, nasal sprays, and ointments. The company is investing in a new USFDA-compliant manufacturing facility to expand production capacity and pursue regulated market approvals.
Is Biodeal Pharmaceuticals a public or private company?
Biodeal Pharmaceuticals is a private company. It is classified as venture growth investor backed and is currently operating.
When was Biodeal Pharmaceuticals founded?
Biodeal Pharmaceuticals was founded in 2005. It employs 1,001 to 5,000 people.
Where is Biodeal Pharmaceuticals based?
Biodeal Pharmaceuticals is headquartered in Noida, India, in the Asia region.
Who are Biodeal Pharmaceuticals's main competitors?
Broad incumbents on record are Zydus Lifesciences (Cadila Healthcare), Sun Pharmaceutical Industries, Cipla, Glenmark Pharmaceuticals, Lupin, Aurobindo Pharma, Dr. Reddy's Laboratories and Torrent Pharmaceuticals. Direct peers are Unichem Laboratories and Morepen Laboratories.
Does Biodeal Pharmaceuticals have an API?
No public API is recorded for Biodeal Pharmaceuticals.
What industry is Biodeal Pharmaceuticals in?
Biodeal Pharmaceuticals's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGAHAB, Small-Molecule API Commercial Manufacturing, with a secondary code of HLAIABAA, Small-Molecule Generics (Branded/Unbranded). Its NAICS code is 325412 and its SIC code is 2834.